Is Li-Fraumeni syndrome hereditary?

Li-Fraumeni syndrome is a hereditary cancer predisposition disorder caused by an inherited germline mutation in the TP53 tumor suppressor gene. Because it follows an autosomal dominant inheritance pattern, an individual with a pathogenic variant has a 50% chance of passing the condition to each of their children.

Is Li-Fraumeni syndrome hereditary?

Yes, Li-Fraumeni syndrome is a hereditary condition, meaning the genetic mutation is passed down through families in the germline (present in every cell of the body). While most cases are inherited from an affected parent, it is important to distinguish between "hereditary" and "de novo" cases. In approximately 7% to 20% of Li-Fraumeni syndrome cases, the mutation occurs as a de novo (spontaneous) event in the individual, meaning neither parent carries the mutation, but that individual can then pass the condition to their own children.

What is the inheritance pattern of Li-Fraumeni syndrome?

Li-Fraumeni syndrome follows an autosomal dominant inheritance pattern. "Autosomal" means the gene is located on one of the non-sex chromosomes, and "dominant" means that only one copy of the mutated TP53 gene—inherited from either the mother or the father—is sufficient to cause the syndrome. Because of this, the clinical risk is significant for first-degree relatives of an affected person.

How is genetic testing used for Li-Fraumeni syndrome?

Genetic testing for Li-Fraumeni syndrome is performed through a blood or saliva sample to analyze the TP53 gene for pathogenic variants. Testing is typically recommended for individuals who meet specific clinical criteria, such as the classic Chompret criteria, which include:

• A diagnosis of sarcoma before age 45.


• A first-degree relative with any cancer before age 45.


• A first-degree relative with sarcoma at any age.


• Individuals with multiple primary tumors.

What is the role of genetic counseling for families?

Genetic counseling is a critical component of managing Li-Fraumeni syndrome. A genetic counselor helps families understand the implications of a TP53 mutation, including the high lifetime risk of developing various cancers. For those planning pregnancies, genetic counseling provides a space to discuss reproductive options, such as Preimplantation Genetic Testing (PGT) alongside In Vitro Fertilization (IVF), which allows parents to screen embryos for the specific familial TP53 mutation before implantation. At DiseaseMaps.org, 53 people with Li-Fraumeni syndrome have joined our community, providing a network of support for those navigating these complex medical and reproductive decisions.

Next steps

• Consult with a board-certified genetic counselor to review your family medical history and discuss the appropriateness of TP53 testing.


• If you have been diagnosed with Li-Fraumeni syndrome, seek care at a center specializing in high-risk cancer surveillance to establish a rigorous screening protocol.


• Connect with the 53 members of the DiseaseMaps.org community to share experiences and find peer support.


• Discuss reproductive options, including PGT, with a reproductive endocrinologist if you are considering starting a family.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Li-Fraumeni syndrome overview.


• Orphanet: Rare disease database entry for Li-Fraumeni syndrome (ORPHA:506).


• OMIM (Online Mendelian Inheritance in Man): TP53 gene and Li-Fraumeni syndrome (Entry #151623).


• Li-Fraumeni Syndrome Association (LFSA): Resources for patients and families.